Position in HALO
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$19,263,359
-$1,412,816 QoQ
Shares Held
298,056
-3.0% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SEGALL BRYANT & HAMILL, LLC holds $242,312,554 across 27 Biotechnology names. HALO ranks #4 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
212,714 | $22,420,055 | |
| 2 | TECH |
BIO-TECHNE Corp
|
428,507 | $22,393,775 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
79,497 | $20,535,665 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
298,056 | $19,263,359 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,073 | $17,001,117 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
31,870 | $16,682,988 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
175,898 | $16,249,457 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
195,380 | $13,311,239 |
All Filings in HALO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,263,359 | 298,056 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $20,676,175 | 307,224 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,883,170 | 216,569 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $16,169,376 | 310,830 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,897,741 | 343,171 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $16,881,854 | 353,103 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $20,330,274 | 355,176 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $15,986,555 | 305,320 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,981,972 | 269,960 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,961,691 | 242,470 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,343,071 | 218,405 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $9,489,584 | 263,088 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,084,321 | 185,502 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $10,631,992 | 186,854 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,540,554 | 190,707 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||